Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Jun;7(6):624–627. doi: 10.1111/j.1365-2125.1979.tb04654.x

The levels of anticonvulsants in breast milk.

S Kaneko, T Sato, K Suzuki
PMCID: PMC1429673  PMID: 465285

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kaneko S., Suzuki K., Fukushima Y., Sato T. [Study on carbamazepine serum level in epileptic patients treated only with carbamazepine: with special reference to its efficacy and side effects (author's transl)]. Seishin Shinkeigaku Zasshi. 1978 Sep;80(9):537–560. [PubMed] [Google Scholar]
  2. Kaneko S. [A study on anticonvulsant level in body fluids. 2nd report: Dialyzed serum (free form), CSF and saliva level (author's transl)]. Seishin Shinkeigaku Zasshi. 1978 Jan 25;80(1):29–42. [PubMed] [Google Scholar]
  3. McAuliffe J. J., Sherwin A. L., Leppik I. E., Fayle S. A., Pippenger C. E. Salivary levels of anticonvulsants: a practical approach to drug monitoring. Neurology. 1977 May;27(5):409–413. doi: 10.1212/wnl.27.5.409. [DOI] [PubMed] [Google Scholar]
  4. Mirkin B. L. Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects. J Pediatr. 1971 Feb;78(2):329–337. doi: 10.1016/s0022-3476(71)80025-2. [DOI] [PubMed] [Google Scholar]
  5. Pynnönen S., Kanto J., Sillanpä M., Erkkola R. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol (Copenh) 1977 Sep;41(3):244–253. doi: 10.1111/j.1600-0773.1977.tb02145.x. [DOI] [PubMed] [Google Scholar]
  6. Pynnönen S., Sillanpä M. Letter: Carbamazepine and mother's milk. Lancet. 1975 Sep 20;2(7934):563–563. doi: 10.1016/s0140-6736(75)90950-2. [DOI] [PubMed] [Google Scholar]
  7. Rane A., Bertilsson L., Palmér L. Disposition of placentally transferred carbamazepine (Tegretol) in the newborn. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):283–284. doi: 10.1007/BF00567129. [DOI] [PubMed] [Google Scholar]
  8. SVENSMARK O., SCHILLER P. J., BUCHTHAL F. 5, 5-Diphenylhydantoin (dilantin) blood levels after oral or intravenous dosage in man. Acta Pharmacol Toxicol (Copenh) 1960;16:331–346. doi: 10.1111/j.1600-0773.1960.tb01218.x. [DOI] [PubMed] [Google Scholar]
  9. Vajda F., Williams F. M., Davidson S., Falconer M. A., Breckenridge A. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther. 1974 Jun;15(6):597–603. doi: 10.1002/cpt1974156597. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES